Wan‐Ching Chou

426 total citations
15 papers, 343 citations indexed

About

Wan‐Ching Chou is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Wan‐Ching Chou has authored 15 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Wan‐Ching Chou's work include Sirtuins and Resveratrol in Medicine (3 papers), Mitochondrial Function and Pathology (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Wan‐Ching Chou is often cited by papers focused on Sirtuins and Resveratrol in Medicine (3 papers), Mitochondrial Function and Pathology (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Wan‐Ching Chou collaborates with scholars based in Taiwan, China and Sri Lanka. Wan‐Ching Chou's co-authors include Kun‐Ling Tsai, Pei‐Ling Hsieh, Pei‐Ming Chu, Hsiu‐Chung Ou, Yu‐Ting Huang, Yuting Huang, Shih‐Hung Chan, Yun‐Ching Chang, Ching‐Hsia Hung and I‐Ming Jou and has published in prestigious journals such as International Journal of Molecular Sciences, Neuroscience Letters and Molecular Nutrition & Food Research.

In The Last Decade

Wan‐Ching Chou

15 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wan‐Ching Chou Taiwan 9 154 75 52 41 38 15 343
Ke‐Xue Li China 12 207 1.3× 95 1.3× 59 1.1× 43 1.0× 34 0.9× 17 465
Yawei Zheng China 12 156 1.0× 51 0.7× 52 1.0× 29 0.7× 32 0.8× 54 413
Dajun Chai China 12 208 1.4× 80 1.1× 70 1.3× 64 1.6× 34 0.9× 32 423
Santie Li China 11 296 1.9× 58 0.8× 45 0.9× 41 1.0× 33 0.9× 12 547
Wenjuan Liu China 11 215 1.4× 148 2.0× 39 0.8× 31 0.8× 20 0.5× 21 389
Mu-Hsin Chang Taiwan 11 179 1.2× 77 1.0× 25 0.5× 49 1.2× 49 1.3× 17 415
Jiayu Li China 12 106 0.7× 33 0.4× 33 0.6× 45 1.1× 54 1.4× 37 387
Jing‐Ren Jeng Taiwan 12 96 0.6× 85 1.1× 63 1.2× 48 1.2× 18 0.5× 20 368
Ignacio Norambuena‐Soto Chile 11 247 1.6× 82 1.1× 55 1.1× 34 0.8× 23 0.6× 20 504
Biao Xu China 11 201 1.3× 106 1.4× 35 0.7× 50 1.2× 22 0.6× 17 445

Countries citing papers authored by Wan‐Ching Chou

Since Specialization
Citations

This map shows the geographic impact of Wan‐Ching Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan‐Ching Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan‐Ching Chou more than expected).

Fields of papers citing papers by Wan‐Ching Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan‐Ching Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan‐Ching Chou. The network helps show where Wan‐Ching Chou may publish in the future.

Co-authorship network of co-authors of Wan‐Ching Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Wan‐Ching Chou. A scholar is included among the top collaborators of Wan‐Ching Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan‐Ching Chou. Wan‐Ching Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Jou, Yeong‐Chin, et al.. (2024). Ellagic acid protects against angiotensin II ‐induced hypertrophic responses through ROS ‐mediated MAPK pathway in H9c2 cells. Environmental Toxicology. 39(5). 3253–3263. 1 indexed citations
2.
Chou, Wan‐Ching, et al.. (2023). Sesamin suppresses angiotensin‐II‐enhanced oxidative stress and hypertrophic markers in H9c2 cells. Environmental Toxicology. 38(9). 2165–2172. 8 indexed citations
3.
Tsai, Kun‐Ling, et al.. (2023). Mangiferin Protects against Angiotensin-II-Enhanced Hypertrophic Markers and Apoptosis in H9c2 Cardiomyocytes. The American Journal of Chinese Medicine. 51(7). 1865–1878. 1 indexed citations
4.
Hsieh, Pei‐Ling, Kun‐Ling Tsai, Wan‐Ching Chou, et al.. (2023). Cisplatin triggers oxidative stress, apoptosis and pro‐inflammatory responses by inhibiting the SIRT1 ‐mediated Nrf2 pathway in chondrocytes. Environmental Toxicology. 38(10). 2476–2486. 5 indexed citations
5.
Wang, Shih‐Hao, Kun‐Ling Tsai, Wan‐Ching Chou, et al.. (2022). Quercetin Mitigates Cisplatin-Induced Oxidative Damage and Apoptosis in Cardiomyocytes through Nrf2/HO-1 Signaling Pathway. The American Journal of Chinese Medicine. 50(5). 1281–1298. 55 indexed citations
6.
Hsieh, Pei‐Ling, Pei‐Ming Chu, Yuting Huang, et al.. (2022). Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation. International Journal of Molecular Sciences. 23(17). 10146–10146. 83 indexed citations
7.
Jiang, Shi-liang, et al.. (2022). Atorvastatin Ameliorates Doxorubicin-Induced Cardiomyopathy by Regulating the Autophagy–Lysosome Pathway and Its Upstream Regulatory Factor Transcription Factor EB. Journal of Cardiovascular Pharmacology. 80(5). 732–738. 5 indexed citations
8.
Ma, Ching-Hou, Yuting Huang, Zhixiang Wu, et al.. (2022). Effects of percutaneous vertebroplasty on respiratory parameters in patients with osteoporotic vertebral compression fractures. Annals of Medicine. 54(1). 1320–1327. 4 indexed citations
10.
Ma, Ching-Hou, Wan‐Ching Chou, I‐Ming Jou, et al.. (2021). Ginsenoside Rg3 Attenuates TNF-α-Induced Damage in Chondrocytes through Regulating SIRT1-Mediated Anti-Apoptotic and Anti-Inflammatory Mechanisms. Antioxidants. 10(12). 1972–1972. 28 indexed citations
11.
Chou, Wan‐Ching, Kun‐Ling Tsai, Pei‐Ling Hsieh, et al.. (2021). Galectin‐3 facilitates inflammation and apoptosis in chondrocytes through upregulation of the TLR‐4‐mediated oxidative stress pathway in TC28a2 human chondrocyte cells. Environmental Toxicology. 37(3). 478–488. 16 indexed citations
13.
Ou, Hsiu‐Chung, Wan‐Ching Chou, Pei‐Ming Chu, et al.. (2019). Fucoxanthin Protects against oxLDL‐Induced Endothelial Damage via Activating the AMPK‐Akt‐CREB‐PGC1α Pathway. Molecular Nutrition & Food Research. 63(10). e1801353–e1801353. 33 indexed citations
14.
Ou, Hsiu‐Chung, Wan‐Ching Chou, Ching‐Hsia Hung, et al.. (2019). Galectin‐3 aggravates ox‐LDL‐induced endothelial dysfunction through LOX‐1 mediated signaling pathway. Environmental Toxicology. 34(7). 825–835. 38 indexed citations
15.
Loh, Kian Ping, W.H. Wong, Shan Huang, et al.. (2006). A comparison study of cerebral protection using Ginkgo biloba extract and Losartan on stroked rats. Neuroscience Letters. 398(1-2). 28–33. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026